NCT00671697: Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
- State
- Completed
- Phase
- Phase 1
- People
- 13 taking part
- Started
- May 2008
- Primary completion
- Jan 2010
- Arms
- Dose Level 1 Arsenic Trioxide & Decitabine, Dose Level 2 Arsenic Trioxide & Decitabine, Dose Level 3 Arsenic Trioxide & Decitabine
- Results
- None posted
- 5 May 2008: Trial registered